Stock Movement | Dongyang Pharmaceutical (06887) rose over 4% in early trading after the company announced a significant strategic cooperation agreement with XtalPi Holdings.

Dongyangguang Pharmaceutical (06887) rose over 4% in early trading. As of the time of writing, it was up 4.06%, trading at HKD 46.68 with a turnover of HKD 13.8169 million.

Zhitong FinanceJan 27 11:00

Hong Kong Stock Announcements | Dongpeng Beverages begins its IPO subscription today. Joyson Electronic expects an increase of approximately 40.56% in annual net profit attributable to shareholders.

Zijin Gold International proposes to acquire 100% of Allied Gold Corporation for approximately CAD 5.5 billion.

Zhitong FinanceJan 26 23:05

Dongyang Sunshine Pharmaceutical (06887) has entered into a strategic cooperation agreement with Shenzhen XtalPi to establish a joint venture and jointly build an AI-driven drug discovery platform.

Dongyang Sunshine Pharmaceutical (06887) announced that on January 26, 2026, the company entered into a strategic cooperation agreement with Shenzhen XtalPi Technology Co., Ltd. (Shenzhen XtalPi). Under the strategic cooperation agreement, the two parties plan to establish a joint venture to build an AI-driven drug discovery platform, focusing on the following areas of cooperation:

Zhitong FinanceJan 26 19:11

Stock Movement | Dongyangguang Medicine (06887) surged over 6% in the afternoon after its Class 1 new drug, Ologliflozin, was approved for marketing. The company recently launched an AI-powered intelligent R&D platform.

Dongyangguang Pharmaceutical (06887) surged over 6% in the afternoon trading session. As of the time of writing, it was up 6.55%, trading at HKD 46.2 with a turnover of HKD 30.6289 million.

Zhitong FinanceJan 22 14:06

Sunshine Lake Pharma Gets China Nod for Marketing of Glycemic Control Drug

MT NewswiresJan 16 20:27

Hong Kong Stock Announcements | Wuxi XDC Makes a Cash Offer for TOT Biopharm-B at a Premium of Approximately 99%; Trading Resumes on January 15

CITIC Securities (06030) reported a net profit attributable to shareholders of 30.051 billion yuan for the fiscal year 2025, representing a year-on-year increase of 38.46%. Wuxi XDC (02268) announced an expected year-on-year growth of over 38% in net profit for the fiscal year 2025.

Zhitong FinanceJan 14 23:05